Home » Newsletters » BioWorld Science

BioWorld Science

May 12, 2003

View Archived Issues

Once-monthly octreotide acetate improves visual acuity in cystoid macular edema

Antiviral and antiinflammatory effects for N-chlorotaurine in adenoviral keratoconjunctivitis

Tripep to acquire Isconova

Development of CEL-1000 for herpes simplex funded by NIAID

Initiation of phase I clinical trial of TTS-CD3 in patients with NSCLC

PDL discontinues development of anti-IL-4 antibody for asthma

NeoPharm granted FDA permission for LEP-ETU clinical trial

Xcyte T-cell product enters phase I/II trial in multiple myeloma

Abgenix and Sosei enter CRTH2-targeting antibody development agreement

Genentech and ABC(2) to collaborate on Tarceva brain cancer trial

Dendreon uses telomerase in new cancer immunotherapy

Emisphere's oral insulin candidate enters clinical testing

Vancomycin-cephalosporin conjugates prepared and tested at Theravance

Roche describes another series of adenosine A2A receptor modulators

Tularik reports IRAK inhibitors and their use in inflammatory, proliferative and immune disorders

Dual 5-HT reuptake inhibitors/5-HT1A agonists described in Wyeth patent

Novel H3 receptor modulators designed by Novo Nordisk and Boehringer Ingelheim team

Debio presents new camptothecin prodrugs in recent patent

New PDE5 inhibitors under study at Merck KGaA

Enanta claims new ciclosporin analogues with utility in asthma therapy

Pharmacia (now Pfizer) presents new 5-HT6 receptor ligands

Novartis scientists discover novel steryl sulfatase inhibitors for acne, hirsutism, etc.

Cozaar approved for diabetics with kidney disease and high blood pressure in Canada

Chugai research operations to close in U.S.

Second Merck antibody advances to phase II trials

Licensing opportunity from Milkhaus: ML-04 for BPH and prostatitis

Multivalent Fab molecule targeting ICAM-1 prevents HRV infection

SUN-C8079, a new NF-kB inhibitor, evaluated in vitro and in vivo

New antibacterial agent activated by L-tryptophanase, a bacteria-specific enzyme

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...